Synthesis of factor D by normal human hepatocytes

International Archives of Allergy and Immunology

Volumn 122, Issue 4, 2000, Pages 299-302

  Kitano, Etsuko ^a   Kitamura, Hajime ^a  

^a Osaka Prefecture University   (Japan)

Author keywords

Complement synthesis; Factor D; Hepatocytes

Indexed keywords

COMPLEMENT FACTOR D; CYCLOHEXIMIDE;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIVER CELL; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS;

EID: 0033813601     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024413     Document Type: Article

References (16)

1. Nilsson B, Ekdahl KN: Component of the alternative pathway; in Rother K, Till GO, Haensch GM (eds): The Complement System, ed 2. Berlin, Springer, 1998, pp 23-49.
2. Morgan BP: Complement: Clinical Aspects and Relevance to Disease. London, Academic Press, 1990, pp 8-35.
3. White RT, Damm D, Hancock N, Rosen BS, Lowell BB, Usher P, Flier JS, Spiegelman BM: Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. Biol Chem 1992;267:9210-9213.
4. Choy LN, Rosen BS, Spiegelman BM: Adipsin and an endogenous pathway of complement from adipose cells. J Biol Chem 1992;267: 12736-12741.
5. Morgan BP, Gasque P: Extrahepatic complement biosynthesis: Where, when and why? Clin Exp Immunol 1997;107:1-7.
6. Barnum SR, Volanakis JE: Biosynthesis of complement protein D by HepG2 cells: A comparison of D produced by HepG2 cells, U937 cells and blood monocytes. Eur J Immunol 1985;15:1148-1151.
7. Barnum SR, Ishii Y, Agrawal A, Volanakis JE: Production and interferon-γ-mediated regulation of complement component C2 and factors B and D by astroglioma cell line U105-MG. Biochem J 1992;287:595-601.
8. Whaley K: Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J Exp Med 1980; 151:501-506.
9. Miyama A, Kato T, Horai S: Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex. Biken J 1975;18:193-204.
10. Whaley K, North J: Haemolytic assay for whole complement activity and individual components: in Dodds AW. Sim RB (eds): Complement. Oxford, IRL Press, 1997, pp 19-47.
11. Kitano E, Kitamura H: Synthesis of the third component complement (C3) by human gastric cancer-derived cell lines. Clin Exp Immunol 1993;94:273-278.
12. Andoh A, Fujiyama Y, Bamba T, Hosada S: Differential cytokine regulation of complement C3, C4 and factor B synthesis in human intestinal epithelial cell line Caco-2. J Immunol 1993; 151:4239-4247.
13. Yamauchi Y, Stevens JW, Macon KJ, Volanakis JE: Recombinant and native zymogen forms of human complement factor D. J Immunol 1994;152:3645-3653.
14. Jing H, Macon KJ, Moore D, Delucas LJ, Volanakis JE, Narayana SVL: Structural basis of profactor D activation: from a highly flexible zymogen to a novel self-inhibited serine protease, complement factor D. EMBO J 1999;18: 804-814.
15. Williams PL, Warwick R, Dyson M, Bannister LH (eds): The liver; in Gray's Anatomy, ed 37. London, Churchill Livingston, 1989, pp 1384-1398.
16. Pascual M, Steiger G, Estreicher L, Macon K, Volanakis JE, Schifferli JA: Metabolism of complement factor D in renal failure. Kidney Int 1988;34:529-536.